Immunohistochemistry HER2 ERBB2 Breast Test
Introduction
The Immunohistochemistry HER2 ERBB2 Breast Test is a vital diagnostic tool used in the evaluation of breast cancer. This test measures the expression of the HER2 protein, which is an important factor in determining the aggressiveness of breast cancer and the most effective treatment options. The presence of HER2 can significantly influence the treatment plan, making this test essential for oncologists and pathologists.
What the Test Measures
This test specifically detects the overexpression of the HER2 protein in breast tissue samples. HER2 (Human Epidermal Growth Factor Receptor 2) is a gene that can play a role in the development of breast cancer. By assessing the levels of HER2, healthcare providers can better understand the tumor’s characteristics and how it may respond to certain therapies.
Who Should Consider This Test?
Patients diagnosed with breast cancer or those exhibiting symptoms such as:
- Unexplained lumps in the breast
- Changes in breast shape or size
- Nipple discharge or changes
- Family history of breast cancer
Additionally, individuals at high risk for breast cancer due to genetic factors should also consider this test.
Benefits of Taking the Test
The Immunohistochemistry HER2 ERBB2 Breast Test offers several benefits, including:
- Guiding treatment decisions, especially regarding targeted therapies like trastuzumab (Herceptin).
- Helping to predict prognosis and potential outcomes for patients with breast cancer.
- Enabling personalized treatment plans based on the tumor’s HER2 status.
- Facilitating early detection of aggressive cancer types, leading to timely intervention.
Understanding Your Results
Results from the Immunohistochemistry HER2 ERBB2 Breast Test are typically categorized as positive, negative, or equivocal. A positive result indicates a high level of HER2 protein, which may suggest a more aggressive cancer type and a potential benefit from HER2-targeted therapies. An equivocal result may require further testing or evaluation. It is crucial to discuss your results with your oncologist to understand the implications for your treatment.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry HER2 ERBB2 Breast Test | 36738 NGN | 40820 NGN |
Book the Test
To ensure the best possible care and treatment for breast cancer, consider booking the Immunohistochemistry HER2 ERBB2 Breast Test today. For more information or to schedule your test, please call or WhatsApp us at +2348077798758. Our team is here to assist you with any questions and guide you through the booking process.
Additional Information
Turnaround Time: Sample Daily by 6 pm; Report Block: 5 days for Tissue Biopsy, 7 days for Tissue Large Complex.
Sample Type: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.
Pre-Test Instructions: Provide a copy of the Histopathology report, Site of biopsy, and Clinical history.
This test is performed using the Immunohistochemistry method and is essential for patients with cancer, particularly those under the care of oncologists and pathologists.
